Allianz Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-936,921
| Closed | -$93M | – | 2934 |
|
|
2019
Q3 | $93M | Buy |
936,921
+208,792
| +29% | +$19.8M | 0.09% | 245 |
|
|
2019
Q2 | $67.3M | Buy |
728,129
+49,983
| +7% | +$4.75M | 0.06% | 339 |
|
|
2019
Q1 | $64M | Sell |
678,146
-455,511
| -40% | -$39.8M | 0.06% | 334 |
|
|
2018
Q4 | $72.7M | Buy |
1,133,657
+345,979
| +44% | +$25.5M | 0.08% | 274 |
|
|
2018
Q3 | $70.5M | Buy |
787,678
+59,355
| +8% | +$5.25M | 0.06% | 332 |
|
|
2018
Q2 | $57.8M | Sell |
728,323
-192,328
| -21% | -$16M | 0.06% | 357 |
|
|
2018
Q1 | $82.1M | Sell |
920,651
-1,121,788
| -55% | -$108M | 0.08% | 284 |
|
|
2017
Q4 | $213M | Buy |
2,042,439
+409,828
| +25% | +$46.2M | 0.17% | 115 |
|
|
2017
Q3 | $238M | Buy |
1,632,611
+4,685
| +0.3% | +$638K | 0.21% | 91 |
|
|
2017
Q2 | $212M | Sell |
1,627,926
-234,508
| -13% | -$28.7M | 0.2% | 90 |
|
|
2017
Q1 | $232M | Buy |
1,862,434
+245,381
| +15% | +$29.4M | 0.23% | 72 |
|
|
2016
Q4 | $187M | Sell |
1,617,053
-192,633
| -11% | -$21.5M | 0.17% | 133 |
|
|
2016
Q3 | $188M | Sell |
1,809,686
-293,184
| -14% | -$31.7M | 0.18% | 116 |
|
|
2016
Q2 | $207M | Sell |
2,102,870
-21,304
| -1% | -$2.2M | 0.22% | 91 |
|
|
2016
Q1 | $213M | Buy |
2,124,174
+149,131
| +8% | +$15.4M | 0.24% | 84 |
|
|
2015
Q4 | $237M | Sell |
1,975,043
-532,755
| -21% | -$61.6M | 0.27% | 74 |
|
|
2015
Q3 | $271M | Sell |
2,507,798
-40,215
| -2% | -$4.99M | 0.32% | 60 |
|
|
2015
Q2 | $295M | Buy |
2,548,013
+117,349
| +5% | +$13.4M | 0.31% | 67 |
|
|
2015
Q1 | $280M | Sell |
2,430,664
-293,176
| -11% | -$35M | 0.32% | 71 |
|
|
2014
Q4 | $305M | Buy |
2,723,840
+183,853
| +7% | +$19.4M | 0.34% | 65 |
|
|
2014
Q3 | $241M | Buy |
2,539,987
+52,694
| +2% | +$4.76M | 0.29% | 74 |
|
|
2014
Q2 | $214M | Buy |
2,487,293
+58,913
| +2% | +$4.48M | 0.27% | 80 |
|
|
2014
Q1 | $170M | Sell |
2,428,380
-341,616
| -12% | -$27.1M | 0.2% | 111 |
|
|
2013
Q4 | $234M | Sell |
2,769,996
-688,254
| -20% | -$54.5M | 0.3% | 76 |
|
|
2013
Q3 | $267M | Sell |
3,458,250
-933,526
| -21% | -$65.4M | 0.35% | 69 |
|
|
2013
Q2 | $257M | Buy |
+4,391,776
| New | +$264M | 0.36% | 64 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Allianz Asset Management's CELG Position: Q4 2019 in Review
Allianz Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 936,921 shares — an estimated $93M sold.
Allianz Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $305M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Allianz Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Allianz Asset Management sold 936,921 Celgene Corp shares in Q4 2019, an estimated $93M.
- Allianz Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Allianz Asset Management's Celgene Corp position peaked at $305M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.